Cargando…

Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients

Background: The aim of this study was to perform a cross-sectional study of Polish neurogenic patients to measure, at the population level, the prevalence, bother and behavior associated with treatment for lower urinary tract symptoms (LUTS) and overactive bladder (OAB). Methods: This epidemiologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Przydacz, Mikolaj, Chlosta, Marcin, Golabek, Tomasz, Chlosta, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228720/
https://www.ncbi.nlm.nih.gov/pubmed/34071986
http://dx.doi.org/10.3390/brainsci11060712
_version_ 1783712808522743808
author Przydacz, Mikolaj
Chlosta, Marcin
Golabek, Tomasz
Chlosta, Piotr
author_facet Przydacz, Mikolaj
Chlosta, Marcin
Golabek, Tomasz
Chlosta, Piotr
author_sort Przydacz, Mikolaj
collection PubMed
description Background: The aim of this study was to perform a cross-sectional study of Polish neurogenic patients to measure, at the population level, the prevalence, bother and behavior associated with treatment for lower urinary tract symptoms (LUTS) and overactive bladder (OAB). Methods: This epidemiological study was based on data from LUTS POLAND, a computer-assisted and population-representative telephone survey. Participants were classified by age, sex and place of residence. Results: LUTS POLAND includes 6005 completed interviews, of which 1166 (19.4%) were for individuals who had ever received any treatment by neurologists and/or neurosurgeons. Among these neurogenic participants, LUTS prevalence was 72.3%, statistically higher than for non-neurogenic respondents. At the population level, neurogenic patients had about a 20% higher risk for LUTS presence than non-neurogenic participants (relative risk: 1.17–1.21). LUTS prevalence did not differ between men and women. Frequency was the most common of the LUTS. Forty percent of neurogenic respondents described having more than one LUTS subtype (i.e., storage, voiding, and/or post-micturition symptom subtype), and more than 50% of respondents reported OAB symptoms. Both storage and voiding symptoms were bothersome, and many neurogenic individuals (42.3–51.0%) expressed anxiety about bladder function affecting quality of life. Only one-third (34.9–36.6%) of neurogenic participants had sought treatment for their LUTS, and the majority of such individuals received and maintained treatment. Conclusions: LUTS and OAB symptoms were highly prevalent and bothersome among Polish neurogenic patients at the population level. Because the scale of seeking treatment for LUTS was low, Polish neurogenic patients may not be adequately informed about multiple effects of LUTS and OAB.
format Online
Article
Text
id pubmed-8228720
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82287202021-06-26 Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients Przydacz, Mikolaj Chlosta, Marcin Golabek, Tomasz Chlosta, Piotr Brain Sci Article Background: The aim of this study was to perform a cross-sectional study of Polish neurogenic patients to measure, at the population level, the prevalence, bother and behavior associated with treatment for lower urinary tract symptoms (LUTS) and overactive bladder (OAB). Methods: This epidemiological study was based on data from LUTS POLAND, a computer-assisted and population-representative telephone survey. Participants were classified by age, sex and place of residence. Results: LUTS POLAND includes 6005 completed interviews, of which 1166 (19.4%) were for individuals who had ever received any treatment by neurologists and/or neurosurgeons. Among these neurogenic participants, LUTS prevalence was 72.3%, statistically higher than for non-neurogenic respondents. At the population level, neurogenic patients had about a 20% higher risk for LUTS presence than non-neurogenic participants (relative risk: 1.17–1.21). LUTS prevalence did not differ between men and women. Frequency was the most common of the LUTS. Forty percent of neurogenic respondents described having more than one LUTS subtype (i.e., storage, voiding, and/or post-micturition symptom subtype), and more than 50% of respondents reported OAB symptoms. Both storage and voiding symptoms were bothersome, and many neurogenic individuals (42.3–51.0%) expressed anxiety about bladder function affecting quality of life. Only one-third (34.9–36.6%) of neurogenic participants had sought treatment for their LUTS, and the majority of such individuals received and maintained treatment. Conclusions: LUTS and OAB symptoms were highly prevalent and bothersome among Polish neurogenic patients at the population level. Because the scale of seeking treatment for LUTS was low, Polish neurogenic patients may not be adequately informed about multiple effects of LUTS and OAB. MDPI 2021-05-27 /pmc/articles/PMC8228720/ /pubmed/34071986 http://dx.doi.org/10.3390/brainsci11060712 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Przydacz, Mikolaj
Chlosta, Marcin
Golabek, Tomasz
Chlosta, Piotr
Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients
title Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients
title_full Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients
title_fullStr Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients
title_full_unstemmed Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients
title_short Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients
title_sort population-based study of prevalence, bother and behavior related to treatment for lower urinary tract symptoms and overactive bladder among polish neurogenic patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228720/
https://www.ncbi.nlm.nih.gov/pubmed/34071986
http://dx.doi.org/10.3390/brainsci11060712
work_keys_str_mv AT przydaczmikolaj populationbasedstudyofprevalencebotherandbehaviorrelatedtotreatmentforlowerurinarytractsymptomsandoveractivebladderamongpolishneurogenicpatients
AT chlostamarcin populationbasedstudyofprevalencebotherandbehaviorrelatedtotreatmentforlowerurinarytractsymptomsandoveractivebladderamongpolishneurogenicpatients
AT golabektomasz populationbasedstudyofprevalencebotherandbehaviorrelatedtotreatmentforlowerurinarytractsymptomsandoveractivebladderamongpolishneurogenicpatients
AT chlostapiotr populationbasedstudyofprevalencebotherandbehaviorrelatedtotreatmentforlowerurinarytractsymptomsandoveractivebladderamongpolishneurogenicpatients